MiMedx Announces Release Of 2018 Guidance And Shareholder Conference CallDecember 12, 2017
read more...
Two Independent Poster Abstracts Highlighting The Clinical Efficacy of MiMedx Allografts are Recognized at The 2017 Desert Foot ConferenceDecember 06, 2017
read more...
MiMedx Announces Expectation To Exceed Top End of Fourth Quarter Revenue Guidance Of $88 MillionNovember 30, 2017
read more...